Research & Development

久久爱免费视频在线观看久久爱视频久久爱在线播放视频男孩功课压力大吞胶带笔芯扬言跳楼 父母报警求助


  雲瑯自認為是一只老狐狸,而這群太學生,就是他這只老狐狸看護下的小雞。   曹襄倒吸了一口涼氣道︰“這也太無恥了吧?”久久爱免费视频在线观看   在將霍光分派出去之前,雲瑯就已經做了完全徹底的分割。久久爱视频   阿嬌對皇後衣冠並不在意,依舊穿著自己平日里穿著的常服淡淡的問雲瑯。   劉胥斜著眼楮看了正在拍父皇馬屁的雲哲一下,從手上的奏折中挑選出來一份,放在劉徹面前道︰“啟稟父皇,這是原太史令司馬遷所書的奏折,文章中對父皇近日的行為頗有微詞。”久久爱在线播放视频   宋喬再一次為衛子夫摸過脈門之後,就嘆口氣跪坐在一邊,等待藥效發作。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo